| Latest | F'cast | |
|---|---|---|
| Div Yield | 1.3% | 0.0% |
| Div Cover | 3.8 | 3.7 |
| Op Mrgn | 9.1% | 10.0% |
| ROCE | 8.2% |
| Latest | F'cast | |
|---|---|---|
| P/E | 20.0 | 18.5 |
| PEG | 1.8 | 2.2 |
| Pr/Revenue | 0.5 | 0.4 |
| Pr/Book | 1.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 11.2% | 5.6% |
| PBT | 10.7% | 316.8% |
| EPS | 11.4% | 8.5% |
| DPS | 9.5% | 13.0% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 919.90 | (231.00) | (5.20)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-21 | 1,106.20 | (1.90) | (7.10)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 1,198.50 | 3.90 | 4.20p | 54.3 | n/a | n/a | 0.50p | 0.2% |
| 31-Dec-23 | 1,359.00 | 34.60 | 7.90p | 28.7 | 0.3 | +88% | 2.10p | 0.9% |
| 31-Dec-24 | 1,511.20 | 38.30 | 8.80p | 25.7 | 2.3 | +11% | 2.30p | 1.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 1,595.75 | 159.62 | 9.55p | 18.5 | 2.2 | +8% | 2.60p | 0.0% |
| 31-Dec-26 | 1,683.89 | 187.71 | 15.11p | 11.7 | 0.2 | +58% | 4.00p | 0.0% |
| 31-Dec-27 | 1,774.36 | 210.91 | 19.45p | 9.1 | 0.3 | +29% | 5.13p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Form 8.5 (EPT/RI)-Spire Healthcare Group plc Amend | 05-Dec-2025 | 15:20 | RNS |
| Form 8.3 - The Vanguard Group, Inc.: Spire Healt... | 05-Dec-2025 | 14:44 | EQS Group |
| Form 8.3 SPIRE HEALTHCARE GROUP PLC | 05-Dec-2025 | 14:43 | RNS |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 176.20p |
| Change Today | -5.00p |
| % Change | -2.76 % |
| 52 Week High | 249.00p |
| 52 Week Low | 171.40p |
| Volume | 4,524,365 |
| Shares Issued | 402.76m |
| Market Cap | £709.66m |
| RiskGrade | 165 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 4 |
| Buy | 1 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 6 |

| Latest | Previous | |
|---|---|---|
| Final | Final | |
| Ex-Div | 22-May-25 | 23-May-24 |
| Paid | 20-Jun-25 | 21-Jun-24 |
| Amount | 2.30p | 2.10p |
| Time | Volume / Share Price |
| 16:30 | 300,000 @ 187.53p |
| 13:29 | 1,248,000 @ 181.20p |
| 13:29 | 1,248,000 @ 181.20p |
| 16:36 | 387 @ 176.20p |
| 16:36 | 69,613 @ 176.20p |
| CEO | Justin Ash |
| CFO | Harbant Samra |
You are here: research